Netherlands Pharma News: Argenx to Go it Alone; Agendia Backs Out of IPO; Pleco…
The latest news from the Dutch pharma, biotech and healthcare industries, including the bullish comments of Argenx CEO Tim Van Hauwermeiren following the successful launch of its Vyvgart product; cancer…